MedPath

Preadministration of 6 percent Hydroxy ethyl starch before induction with propofol for reduction of pain on propofol injection.

Not yet recruiting
Conditions
Administration, ,
Registration Number
CTRI/2024/05/067424
Lead Sponsor
Department of anaesthesiology SMS medical college jaipur
Brief Summary

Propofol is most widely used intravenous agent for induction of anaesthesia. The immediate pain is due to irritation of vein and delayed pain is due to kin in release on propofol injection. Colloids have the capacity to modify endothelial cell junctions and permeability of the vascular endothelium by various substances and molecules.With this background we plan to conduct this study to compare the effect of pre-administration of 6% hydroxy ethyl starch for reduction of pain on propofol injection.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Patients undergoing elective surgery under general anaesthesia.
  • Patients willing to give written informed consent.
  • ASA grade 1 and 2.
Exclusion Criteria
  • Patients with history of allergy to propofol or hydroxy ethyl starch Patients with pre-existing renal or hepatic dysfunction.
  • Patients with cardiovascular disease,hypertension,diabetes.
  • Emergency surgeries.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the incidence of pain on propofol injection between the study groups0 second 10 second. 20 second. before loss of verbal contact
Secondary Outcome Measures
NameTimeMethod
To compare the severity of pain on propofol injection between the study groups0 second. 10 second. 20 second. before loss of verbal contact

Trial Locations

Locations (1)

SMS medical college and attached hospitals.

🇮🇳

Jaipur, RAJASTHAN, India

SMS medical college and attached hospitals.
🇮🇳Jaipur, RAJASTHAN, India
Mamta Sharma
Principal investigator
7733019098
dr.mamtasharma18@gamil.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.